NFKB1 and classic Hodgkin lymphoma: EBV-positive cHL cases rely less on cellular mutations for NF-κB activation due to strong viral signaling, while EBV-negative cases involve alternative mechanisms, including genetic mutations, socioeconomic interactions, and distinct HLA associations.